Octreotide Use in Neonates: A Case Series
Authors:
Open Access
- 15 June 2018
- journal article
- research article
- Published by Springer Nature in Drugs in R&D
- Vol. 18 (3) , 191-198
Abstract
Octreotide is a somatostatin analogue and has been used off-label for a variety of conditions. There are no specific guidelines for the use of octreotide in neonates and its safety and efficacy have not been systematically evaluated. The objective of this study is to present our experience of using octreotide therapy in neonates.Keywords
This publication has 24 references indexed in Scilit:
- Antitumor Effects of Somatostatin Analogs in Neuroendocrine TumorsThe Oncologist, 2012
- Octreotide in Hennekam syndrome-associated intestinal lymphangiectasiaWorld Journal of Gastroenterology, 2012
- Octreotide as therapeutic option for congenital idiopathic chylothorax: a case seriesActa Paediatrica, 2011
- Octreotide Treatment of Chylothorax in Pediatric Patients following Cardiothoracic SurgeryCongenital Heart Disease, 2010
- Octreotide for the treatment of chylothorax in neonatesCochrane Database of Systematic Reviews, 2010
- Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature reviewPediatric Surgery International, 2010
- Drugs that suppress TSH or cause central hypothyroidismBest Practice & Research Clinical Endocrinology & Metabolism, 2009
- The use of octreotide to treat congenital chylothoraxJournal of Pediatric Surgery, 2006
- Severe Congenital Chylothorax Treated With OctreotideJournal of Perinatology, 2004
- Continuous Versus Intermittent Subcutaneous Infusion of Octreotide in the Treatment of AcromegalyThe Journal of Clinical Pharmacology, 1995